1
Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of neurofibromatosis type 1
Por Jousma, Edwin, Rizvi, Tilat A., Wu, Jianqiang, Janhofer, David, Dombi, Eva, Dunn, Richard S., Kim, Mi-Ok, Masters, Andrea R., Jones, David R., Cripe, Timothy P., Ratner, Nancy
Publicado no Pediatr Blood Cancer (2015)
Obter o texto integralPublicado no Pediatr Blood Cancer (2015)
Obter o texto integral
Obter o texto integral
Artigo
2
Por Higham, Christine S., Steinberg, Seth M., Dombi, Eva, Perry, Arie, Helman, Lee J., Schuetze, Scott M., Ludwig, Joseph A., Staddon, Arthur, Milhem, Mohammed M., Rushing, Daniel, Jones, Robin L., Livingston, Michael, Goldman, Stewart, Moertel, Christopher, Wagner, Lars, Janhofer, David, Annunziata, Christina M., Reinke, Denise, Long, Lauren, Viskochil, David, Baker, Larry, Widemann, Brigitte C.
Publicado no Sarcoma (2017)
Obter o texto integralPublicado no Sarcoma (2017)
Obter o texto integral
Obter o texto integral
Artigo